Home › Agent Hub › Agent Tools › Part D coverage by drug › Atrovent
Agent Tools
Atrovent is a brand of ipratropium. What agents check before quoting it: how many 2027 Part D plans cover it, on which tier, with what restrictions and copays, by plan type, carrier and state.
In 2027, 3,400 of 5,492 Medicare Part D and Medicare Advantage drug plans (61.9%) list Atrovent on their formulary, across 123 of 286 formularies. The most common placement is tier 4 (2,782 plans, 81.8% of those covering it). 884 of the covering plans require prior authorization (26%), 0 step therapy and 3,386 a quantity limit. Generic ipratropium is on 5,492 of 5,492 plans (100%).
194 covering plans charge a flat copay for a 30-day supply at a preferred retail pharmacy after the deductible — median $42, 37 of them $0; 3,206 charge coinsurance instead — median 28% of the drug's cost. Once a member's out-of-pocket drug spending reaches $2,400 in 2027, covered drugs cost $0 for the rest of the year.
2026: 4,005 of 5,496 plans covered it (72.9%); 2027: 3,400 of 5,492 (61.9%).
Of 4,367 plans offered in both years, 13 added it to the formulary and 563 dropped it.
Among plans covering it both years, 25 moved it to a higher tier and 232 to a lower one; 0 added prior authorization and 0 removed it.
| Tier | Plans |
|---|---|
| Tier 1 | 71 |
| Tier 3 | 547 |
| Tier 4 | 2,782 |
| Plan type | Plans covering | Share | Prior auth |
|---|---|---|---|
| Stand-alone Part D (PDP) | 196 of 323 | 60.7% | 52% |
| Medicare Advantage with drugs (MA-PD) | 1,935 of 3,200 | 60.5% | 28% |
| Special needs plans (SNP) | 1,269 of 1,969 | 64.4% | 18.9% |
| Carrier | Plans covering | Usual tier | Prior auth |
|---|---|---|---|
| Humana | 846 of 846 | Tier 4 | 846 |
| UnitedHealthcare | 0 of 830 | No tier listed | 0 |
| Devoted Health | 728 of 728 | Tier 4 | 0 |
| Aetna Medicare | 631 of 631 | Tier 4 | 0 |
| Wellcare | 268 of 268 | Tier 3 | 0 |
| HealthSpring | 0 of 226 | No tier listed | 0 |
| Kaiser Permanente | 0 of 112 | No tier listed | 0 |
| SCAN Health Plan | 83 of 83 | Tier 3 | 0 |
| Highmark Blue Cross Blue Shield or Highmark Blue Shield | 0 of 80 | No tier listed | 0 |
| Alignment Health Plan | 0 of 77 | No tier listed | 0 |
| Anthem Blue Cross and Blue Shield | 74 of 74 | Tier 4 | 0 |
| Wellpoint | 63 of 63 | Tier 4 | 0 |
| Priority Health Medicare | 0 of 40 | No tier listed | 0 |
| CarePlus Health Plans, Inc. | 37 of 37 | Tier 4 | 37 |
| Zing Health | 36 of 36 | Tier 4 | 0 |
| Capital Blue Cross | 0 of 35 | No tier listed | 0 |
| Prominence Health Plan | 0 of 29 | No tier listed | 0 |
| Medica | 0 of 27 | No tier listed | 0 |
| Anthem HealthKeepers | 26 of 26 | Tier 4 | 0 |
| Blue Cross Blue Shield of Michigan | 26 of 26 | Tier 4 | 0 |
| State | Plans covering | Share |
|---|---|---|
| Alabama | 75 of 114 | 65.8% |
| Alaska | 6 of 9 | 66.7% |
| American Samoa | 0 of 1 | 0% |
| Arizona | 94 of 147 | 63.9% |
| Arkansas | 60 of 85 | 70.6% |
| California | 193 of 397 | 48.6% |
| Colorado | 59 of 106 | 55.7% |
| Connecticut | 44 of 54 | 81.5% |
| Delaware | 25 of 43 | 58.1% |
| District of Columbia | 4 of 12 | 33.3% |
| Florida | 369 of 545 | 67.7% |
| Georgia | 98 of 149 | 65.8% |
| Guam | 0 of 1 | 0% |
| Hawaii | 34 of 50 | 68% |
| Idaho | 25 of 45 | 55.6% |
| Illinois | 91 of 132 | 68.9% |
| Indiana | 106 of 138 | 76.8% |
| Iowa | 41 of 64 | 64.1% |
| Kansas | 62 of 84 | 73.8% |
| Kentucky | 92 of 121 | 76% |
| Louisiana | 88 of 125 | 70.4% |
| Maine | 39 of 52 | 75% |
| Maryland | 29 of 49 | 59.2% |
| Massachusetts | 60 of 89 | 67.4% |
| Michigan | 109 of 182 | 59.9% |
| Minnesota | 13 of 63 | 20.6% |
| Mississippi | 73 of 104 | 70.2% |
| Missouri | 121 of 170 | 71.2% |
| Montana | 21 of 27 | 77.8% |
| Nebraska | 31 of 51 | 60.8% |
| Nevada | 49 of 100 | 49% |
| New Hampshire | 17 of 25 | 68% |
| New Jersey | 45 of 73 | 61.6% |
| New Mexico | 29 of 68 | 42.6% |
| New York | 146 of 215 | 67.9% |
| North Carolina | 102 of 176 | 58% |
| North Dakota | 8 of 26 | 30.8% |
| Northern Mariana Islands | 0 of 1 | 0% |
| Ohio | 103 of 171 | 60.2% |
| Oklahoma | 50 of 81 | 61.7% |
| Oregon | 56 of 92 | 60.9% |
| Pennsylvania | 140 of 323 | 43.3% |
| Puerto Rico | 44 of 64 | 68.8% |
| Rhode Island | 12 of 29 | 41.4% |
| South Carolina | 58 of 89 | 65.2% |
| South Dakota | 12 of 30 | 40% |
| Tennessee | 113 of 156 | 72.4% |
| Texas | 260 of 407 | 63.9% |
| U.S. Virgin Islands | 0 of 1 | 0% |
| Utah | 32 of 53 | 60.4% |
| Vermont | 11 of 14 | 78.6% |
| Virginia | 95 of 144 | 66% |
| Washington | 64 of 114 | 56.1% |
| West Virginia | 45 of 69 | 65.2% |
| Wisconsin | 45 of 96 | 46.9% |
| Wyoming | 9 of 13 | 69.2% |
Medicare Part D paid for 256,286 30-day fills of Atrovent in 2024 for about 62,557 enrollees, at an average total cost of $450.11 per 30-day fill (CMS Part D Prescribers by Geography and Drug, national).
Price Atrovent and the rest of a client's list on every plan in their county.
Estimate Atrovent costs by plan
Free tools for licensed insurance agents. Data from CMS public files; verify with plan documents before advising a client.
Counts are over every Medicare Advantage drug plan and stand-alone Part D plan in the CMS monthly formulary files, excluding employer plans. A plan counts as covering a drug when any strength or form of it is on the plan’s formulary; the tier, prior authorization, step therapy and quantity limit shown are the most favorable version on that formulary. Copays are for a 30-day supply at a preferred retail pharmacy after the deductible. This is a reference for licensed agents, not a plan recommendation; verify with the plan’s formulary before advising a client. Source: CMS Part D formulary files (release 10/08/2026). CMS formulary data.